share

Pd-1/Pd-L1 Inhibitor 3 CAS NO 1629654-95-0


Unit Price:

CAS No.:1629654-95-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Pd-1/Pd-L1 Inhibitor 3 is a potent and selective small-molecule inhibitor designed to target the PD-1/PD-L1 immune checkpoint pathway. This compound matters for its potential to modulate the tumor microenvironment and enhance T-cell-mediated anti-tumor immunity, offering a promising avenue for cancer immunotherapy research. It is primarily needed by pharmaceutical R&D teams and academic researchers focused on developing novel oncology therapeutics and studying immune evasion mechanisms in various cancers.

Application

  • Immuno-oncology Research: A key tool compound for in vitro and in vivo studies investigating the PD-1/PD-L1 signaling axis and its role in cancer immune evasion.
  • Drug Discovery & Development: Serves as a lead compound or reference standard in high-throughput screening and structure-activity relationship (SAR) studies for novel immune checkpoint inhibitors.
  • Preclinical Studies: Used to evaluate the efficacy of PD-1/PD-L1 blockade in combination with other therapies, such as chemotherapy, radiotherapy, or other immunomodulators.
  • Biochemical Assays: Employed in binding affinity studies, cellular reporter assays, and other mechanistic studies to understand inhibitor potency and specificity.
  • Academic Research: Facilitates fundamental research into T-cell biology, immune tolerance, and the tumor microenvironment across various cancer models.

Basic Information

Item Details
Product Name Pd-1/Pd-L1 Inhibitor 3
CAS No. 1629654-95-0
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms PD-1/PD-L1 Inhibitor 3; BMS-8; BMS-8 (PD-1/PD-L1 inhibitor); (S)-1-((S)-2-(1H-Indol-3-yl)-1-(4-(5-methoxy-7-methyl-1H-indol-4-yl)piperazin-1-yl)ethyl)pyrrolidine-2-carboxamide; BMS-202; Nivolumab analogue small molecule inhibitor; PD-1/PD-L1 interaction inhibitor 3; Immune checkpoint small molecule inhibitor.
EINECS Contact for details

Quality Control

Our Pd-1/Pd-L1 Inhibitor 3 is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for research use. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment to guarantee batch-to-batch consistency and traceability.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under an inert atmosphere. The product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to maintain stability and potency. Allow the vial to warm to room temperature in a desiccator before opening to prevent condensation.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms to reference standard
Identification (MS) Conforms to structure
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 1.0%
Residual Solvents (GC) Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.